Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:17 PM
Ignite Modification Date:
2025-12-24 @ 7:17 PM
NCT ID:
NCT02170103
Eligibility Criteria:
Inclusion Criteria:
* Patients presenting to participating centers with chest pain and EKG evidence of an acute STEMI (two contiguous leads with \>0.1 millivolt (mV) ST elevation or \>0.1 ST depression in V2-V4) will be asked to participate. The inclusion criteria will be:
1. Age ≥30 years.
2. Eligible for emergent PCI/antithrombotic/antiplatelet therapy.
3. Adequate apical and/or parasternal images by echocardiography.
4. No contraindications or hypersensitivities to ultrasound contrast agents.
Exclusion Criteria:
1. Known or suspected hypersensitivity to ultrasound contrast agent used for the study.
2. Cardiogenic Shock
3. Life expectancy of less than two months or terminally ill.
4. Known severe cardiomyopathy.
5. Known bleeding diathesis or contraindication to glycoprotein 2b/3a inhibitors, anticoagulants, or aspirin
6. Known large right to left intracardiac shunts.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Study:
NCT02170103
Study Brief:
Protocol Section:
NCT02170103